POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)
| Autor: | Lambers Heerspink, H., Jardine, M., Kohan, D., Lafayette, R., Levin, A., Liew, A., Zhang, H., Glicklich, A., Camargo, M., King, A., Barratt, J. |
|---|---|
| Zdroj: | In Kidney International Reports February 2022 7(2) Supplement:S229-S230 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|